Saturday 17 October 2026
Export MTD’s income statement to Excel — free account
Mettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.
1,622.29
16.75
−1.02%
Follow MTD
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(414.19%) | (1,154.87%) | (781.77%) | (736.36%) | |
Piotroski F-Score |
8 | 5 | 6 | 8 | |
| 24.43% | 25.00% | 25.35% | 25.61% | ||
ROIC |
36.64% | 33.91% | 33.09% | 35.40% | |
Return on Tangible Assets |
92.16% | 86.04% | 83.03% | 92.52% | |
Average Days of Receivables |
63.64 | 70.55 | 63.21 | 64.59 | |
Free Cash Flow per Share |
43.41 | 41.18 | 39.13 | 42.94 | |
Free Cash Flow |
890.38 | 848.65 | 793.83 | 863.97 | |
Capital Expenditures |
(106.00) | (107.12) | (107.28) | (111.20) | |
| Other line items | |||||
Cash ROIC |
43.87% | 38.66% | 35.32% | 39.70% | |
Accounts Receivable Turnover |
5.95 | 5.50 | 6.07 | 5.85 | |
Accounts Payable Turnover |
7.05 | 6.78 | 7.76 | 7.37 | |
Inventory Turnover |
4.08 | 4.48 | 4.37 | 4.11 | |
Average Days of Payables |
56.89 | 59.50 | 50.01 | 51.05 | |
Days of Inventory on Hand |
92.40 | 86.41 | 88.52 | 91.43 | |
Tax Rate |
(0.19) | (0.17) | (0.17) | (0.17) | |
Research and Development Expense of Revenue |
4.99% | 4.95% | 5.00% | 5.03% | |
Selling, General and Administrative Expense of Revenue |
24.76% | 24.79% | 24.79% | 24.91% | |
Share Based Compensation of Revenue |
0.57% | 0.56% | 0.56% | 0.55% | |
Interest Coverage |
16.08 | 16.32 | 16.34 | 16.94 | |
Operating CF/Net income |
1.19 | 1.10 | 1.03 | 1.08 | |
Depreciation/Fixed assets |
0.15 | 0.15 | 0.16 | 0.16 | |
Capex/Depreciation |
(0.86) | (0.85) | (0.83) | (0.85) | |
Revenue per Share |
192.18 | 195.36 | 201.61 | 205.44 | |
Operating CF per Share |
48.58 | 46.37 | 44.42 | 48.46 | |
Capex per Share |
(5.17) | (5.20) | (5.29) | (5.53) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates